Multiple step pattern as a biomarker in Parkinson disease

Tanya Blekher, Marjorie Weaver, Jason Rupp, William C. Nichols, Siu L. Hui, Jacqueline Gray, Robert D. Yee, Joanne Wojcieszek, Tatiana Foroud

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objective: To evaluate quantitative measures of saccades as possible biomarkers in early stages of Parkinson disease (PD) and in a population at-risk for PD. Methods: The study sample (n = 68) included mildly to moderately affected PD patients, their unaffected siblings, and control individuals. All participants completed a clinical evaluation by a movement disorder neurologist. Genotyping of the G2019S mutation in the LRRK2 gene was performed in the PD patients and their unaffected siblings. A high resolution, video-based eye tracking system was employed to record eye positions during a battery of visually guided, anti-saccadic (AS), and two memory-guided (MG) tasks. Saccade measures (latency, velocity, gain, error rate, and multiple step pattern) were quantified. Results: PD patients and a subgroup of their unaffected siblings had an abnormally high incidence of multiple step patterns (MSP) and reduced gain of saccades as compared with controls. The abnormalities were most pronounced in the more challenging version of the MG task. For this task, the MSP measure demonstrated good sensitivity (87%) and excellent specificity (96%) in the ability to discriminate PD patients from controls. PD patients and their siblings also made more errors in the AS task. Conclusions: Abnormalities in eye movement measures appear to be sensitive and specific measures in PD patients as well as a subset of those at-risk for PD. The inclusion of quantitative laboratory testing of saccadic movements may increase the sensitivity of the neurological examination to identify individuals who are at greater risk for PD.

Original languageEnglish (US)
Pages (from-to)506-510
Number of pages5
JournalParkinsonism and Related Disorders
Volume15
Issue number7
DOIs
StatePublished - Aug 1 2009

Fingerprint

Parkinson Disease
Biomarkers
Saccades
Siblings
Aptitude
Neurologic Examination
Movement Disorders
Eye Movements
Mutation
Incidence
Genes

Keywords

  • Multiple step pattern
  • Parkinson disease
  • Saccade

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology

Cite this

Multiple step pattern as a biomarker in Parkinson disease. / Blekher, Tanya; Weaver, Marjorie; Rupp, Jason; Nichols, William C.; Hui, Siu L.; Gray, Jacqueline; Yee, Robert D.; Wojcieszek, Joanne; Foroud, Tatiana.

In: Parkinsonism and Related Disorders, Vol. 15, No. 7, 01.08.2009, p. 506-510.

Research output: Contribution to journalArticle

Blekher, Tanya ; Weaver, Marjorie ; Rupp, Jason ; Nichols, William C. ; Hui, Siu L. ; Gray, Jacqueline ; Yee, Robert D. ; Wojcieszek, Joanne ; Foroud, Tatiana. / Multiple step pattern as a biomarker in Parkinson disease. In: Parkinsonism and Related Disorders. 2009 ; Vol. 15, No. 7. pp. 506-510.
@article{847103c648e0440c8fd660b544692118,
title = "Multiple step pattern as a biomarker in Parkinson disease",
abstract = "Objective: To evaluate quantitative measures of saccades as possible biomarkers in early stages of Parkinson disease (PD) and in a population at-risk for PD. Methods: The study sample (n = 68) included mildly to moderately affected PD patients, their unaffected siblings, and control individuals. All participants completed a clinical evaluation by a movement disorder neurologist. Genotyping of the G2019S mutation in the LRRK2 gene was performed in the PD patients and their unaffected siblings. A high resolution, video-based eye tracking system was employed to record eye positions during a battery of visually guided, anti-saccadic (AS), and two memory-guided (MG) tasks. Saccade measures (latency, velocity, gain, error rate, and multiple step pattern) were quantified. Results: PD patients and a subgroup of their unaffected siblings had an abnormally high incidence of multiple step patterns (MSP) and reduced gain of saccades as compared with controls. The abnormalities were most pronounced in the more challenging version of the MG task. For this task, the MSP measure demonstrated good sensitivity (87{\%}) and excellent specificity (96{\%}) in the ability to discriminate PD patients from controls. PD patients and their siblings also made more errors in the AS task. Conclusions: Abnormalities in eye movement measures appear to be sensitive and specific measures in PD patients as well as a subset of those at-risk for PD. The inclusion of quantitative laboratory testing of saccadic movements may increase the sensitivity of the neurological examination to identify individuals who are at greater risk for PD.",
keywords = "Multiple step pattern, Parkinson disease, Saccade",
author = "Tanya Blekher and Marjorie Weaver and Jason Rupp and Nichols, {William C.} and Hui, {Siu L.} and Jacqueline Gray and Yee, {Robert D.} and Joanne Wojcieszek and Tatiana Foroud",
year = "2009",
month = "8",
day = "1",
doi = "10.1016/j.parkreldis.2009.01.002",
language = "English (US)",
volume = "15",
pages = "506--510",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "7",

}

TY - JOUR

T1 - Multiple step pattern as a biomarker in Parkinson disease

AU - Blekher, Tanya

AU - Weaver, Marjorie

AU - Rupp, Jason

AU - Nichols, William C.

AU - Hui, Siu L.

AU - Gray, Jacqueline

AU - Yee, Robert D.

AU - Wojcieszek, Joanne

AU - Foroud, Tatiana

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Objective: To evaluate quantitative measures of saccades as possible biomarkers in early stages of Parkinson disease (PD) and in a population at-risk for PD. Methods: The study sample (n = 68) included mildly to moderately affected PD patients, their unaffected siblings, and control individuals. All participants completed a clinical evaluation by a movement disorder neurologist. Genotyping of the G2019S mutation in the LRRK2 gene was performed in the PD patients and their unaffected siblings. A high resolution, video-based eye tracking system was employed to record eye positions during a battery of visually guided, anti-saccadic (AS), and two memory-guided (MG) tasks. Saccade measures (latency, velocity, gain, error rate, and multiple step pattern) were quantified. Results: PD patients and a subgroup of their unaffected siblings had an abnormally high incidence of multiple step patterns (MSP) and reduced gain of saccades as compared with controls. The abnormalities were most pronounced in the more challenging version of the MG task. For this task, the MSP measure demonstrated good sensitivity (87%) and excellent specificity (96%) in the ability to discriminate PD patients from controls. PD patients and their siblings also made more errors in the AS task. Conclusions: Abnormalities in eye movement measures appear to be sensitive and specific measures in PD patients as well as a subset of those at-risk for PD. The inclusion of quantitative laboratory testing of saccadic movements may increase the sensitivity of the neurological examination to identify individuals who are at greater risk for PD.

AB - Objective: To evaluate quantitative measures of saccades as possible biomarkers in early stages of Parkinson disease (PD) and in a population at-risk for PD. Methods: The study sample (n = 68) included mildly to moderately affected PD patients, their unaffected siblings, and control individuals. All participants completed a clinical evaluation by a movement disorder neurologist. Genotyping of the G2019S mutation in the LRRK2 gene was performed in the PD patients and their unaffected siblings. A high resolution, video-based eye tracking system was employed to record eye positions during a battery of visually guided, anti-saccadic (AS), and two memory-guided (MG) tasks. Saccade measures (latency, velocity, gain, error rate, and multiple step pattern) were quantified. Results: PD patients and a subgroup of their unaffected siblings had an abnormally high incidence of multiple step patterns (MSP) and reduced gain of saccades as compared with controls. The abnormalities were most pronounced in the more challenging version of the MG task. For this task, the MSP measure demonstrated good sensitivity (87%) and excellent specificity (96%) in the ability to discriminate PD patients from controls. PD patients and their siblings also made more errors in the AS task. Conclusions: Abnormalities in eye movement measures appear to be sensitive and specific measures in PD patients as well as a subset of those at-risk for PD. The inclusion of quantitative laboratory testing of saccadic movements may increase the sensitivity of the neurological examination to identify individuals who are at greater risk for PD.

KW - Multiple step pattern

KW - Parkinson disease

KW - Saccade

UR - http://www.scopus.com/inward/record.url?scp=67650712202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650712202&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2009.01.002

DO - 10.1016/j.parkreldis.2009.01.002

M3 - Article

C2 - 19211293

AN - SCOPUS:67650712202

VL - 15

SP - 506

EP - 510

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 7

ER -